Sentences with phrase «human therapeutic development»

That nanoparticles can be coupled to different antibodies and retain efficacy suggests flexibility for future applications, including human therapeutic development.

Not exact matches

Chris Sekely CWS Kindergarten teacher since 1996 Penn State University, BS in Human Development University of Pittsburgh, MS in Public Health Antioch College, MEd Waldorf Certification & Gradalis Therapeutic Certification Returning Board Member in 2016 Connie Davis CWS Class teacher since 2003 University of the South, BA English Literature 1985 Manufacturing Management 1986 - 1998 Antioch University, Waldorf Teacher Certification 2008 CWS Faculty Chair 2007 CWS Grades Chair 2012 CWS College Chair 2017 Returning Board Member 2017

This study is among several funded under a public - private partnership established in 2008 between NICHD and the WALTHAM Centre for Pet Nutrition, a division of Mars Inc., to establish a human - animal interaction research program to support studies relevant to child development, health, and the therapeutic use of animals.

«This latest finding provides a concise and direct synthesis pathway that, due to the structure of the products delivered, will likely be quite valuable for the discovery and development of therapeutic agents,» says Micalizio, whose work focuses on the design of organic chemical reaction methods and strategies to improve medicine and human health.

A 2010 survey by the market analysis firm BCC Research identified 113 therapeutic vaccines in development, many already in human trials.

«A significant amount of work remains in the development of teixobactin as a therapeutic antibiotic for human use — we are probably around six to ten years off a drug that doctors can prescribe to patients — but this is a real step in the right direction and now opens the door for improving our in vivo analogues.»

This finding suggests that in human babies, factors that shape the microbiome — natural ones such as breastfeeding, or therapeutic, such as antibiotics — may affect the immune cells in the baby's brain and consequently the brain's development.

Dr Martin Reijns, Senior Research Fellow at the MRC Human Genetics Unit, said: «We hope that this research will inform future studies into the development of improved therapeutic approaches.»

An outlook piece that analyzes data on fully human mAbs, a rapidly growing category of mAbs boasting promising therapeutic advantages, with an eye to trends in their development and approval.

Two recent developments involving the California Institute for Regenerative Medicine (CIRM) again serve to underscore the reality that adult and other non-embryonic avenues of stem cell research are advancing at a far more dramatic pace toward providing actual therapeutic benefits for patients than is human embryonic stem cell research (hESCR).

iTeos and Adimab LLC are collaborating on the discovery, development and commercialization of multiple, antibody - based therapeutic programs, with Adimab using its antibody discovery and optimization platform to identify fully human therapeutic antibodies against targets selected by iTeos.

AMP T2D focuses on type 2 diabetes genetics, seeking to use and supplement the substantial amount of human genetic data available from people with type 2 diabetes, or at risk of developing it, to identify and validate novel molecules and pathways as targets for therapeutic development.

The condition is more common than muscular dystrophy and cystic fibrosis, but the development of new therapeutic concepts is hindered by the fact that unlike muscular dystrophy and cystic fibrosis, where a single mutated gene causing the disease is known, the entire human chromosome 21 (containing around 300 genes) still has to be dissected into individual gene - dose contributions to the DS symptoms.

The use of NHP in biomedical research is justified in the studies of human diseases, to learn more about their causal pathways, their development, their infectiveness and to develop therapeutic and preventive strategies.

With the reference cell census data in hand, the research team is excited to conduct additional studies, including ones involving models or human patients with gastrointestinal conditions — Crohn's disease, ulcerative colitis, gastrointestinal cancers, forms of food allergy, etc. — aimed at identifying changes in gene expression and epithelial structure and function that could reveal new insights and opportunities for therapeutic development.

We believe that leveraging human intuition through creation of a scientific game for drug discovery can not only provide a new avenue to discover therapeutic drugs for protein targets, but can also contribute to the development of new sophisticated algorithms to use in computer aided drug design.

While many important developments impacted the field, two that garnered significant public, political and scientific attention in 2016 were the proliferation of clinics using unproven stem cell «therapies,» and the steps forward in therapeutic modification of human oocytes (unfertilized eggs) through a process called mitochondrial replacement therapy (MRT).

Data from a new study on how antibodies are developed in humans can be utilized to improve the development of therapeutic antibodies for treating human diseases.

The autoimmune therapeutic area represents a broad category of human disease presentations that involve a variety of organ targets and thus presents a significant challenge with respect to the development of therapies designed to re-establish self - tolerance.

In addition to preventive vaccines, such as Gardasil and Cervarix, laboratory research and several human clinical trials are focused on the development of therapeutic HPV vaccines.

Thus, all research on lines of human embryonic stem cells as the cells of various phenotypes derived from these lines should aim to lexploration mechanisms or the development and validation of therapeutic applicable to serious diseases.

This department provides clinicians and researchers with human and technological resources enabling the development of application - oriented projects, with the objective of improving care for cancer patients (assessment and validation of diagnostic, prognostic and patient support tools, as well as development of biomedical devices or therapeutic approaches resulting from basic research).

The I - Stem laboratory is an institution dedicated to the exploration of potential therapeutic applications of human ES and iPS cells and therefore, is rather a scientific center focusing on «Research and Development».

Translational medicine is the integrated application of innovative pharmacology tools, biomarkers, clinical methods, clinical technologies and study designs to improve disease understanding, confidence in human drug targets and increase confidence in drug candidates, understand the therapeutic index in humans, enhance cost - effective decision making in exploratory development and increase phase II success.

Catherine Priest, PhD, VP of Preclinical Development at Neurona, filed the first successful IND application for a human pluripotent stem cell - based therapeutic as a former Senior Director at Geron Corporation.

The project «Preprogrammed versus stochastic clonal evolution of relapsing Acute Myeloid Leukaemia: Impact on disease development and therapeutic responses» will dissect why the subpopulations of primary human blood cancer cells that drive leukaemic relapse resist relevant clinical treatments in vivo.

The A4M promotes the research of practices and protocols that collectively have the potential to optimize the human aging process, with the development of therapeutic protocols and innovative diagnostic tools that can effectively spur longevity treatments.

Its proprietary human response platform provides the company unique insights into cancer and related disease biology and is being leveraged in the discovery and clinical development of its therapeutic candidates.

This study is among several funded under a public - private partnership established in 2008 between NICHD and the WALTHAM Centre for Pet Nutrition, a division of Mars, Inc., to establish a human - animal interaction research program to support studies relevant to child development, health, and the therapeutic use of animals.

WALTHAM scientists work in partnership with research institutions and experts worldwide to improve our understanding of the role of pets can play in enhancing human health, child development and therapeutic programmes.

In addition to being an Adoption Competent Therapist, Penny's clinical specialties include attachment, loss and grief, trauma / PTSD, the neurobiology of human development and trauma, and the therapeutic application of sensory techniques.

Master of Science, Colorado State University, CO; May 2006 Human Development and Family Studies emphasizing Marriage and Family Therapy Bachelor of Science, Houghton College, Houghton, NY; December 1998 Major: Therapeutic Recreation; Minor: Psychology Associate of Science, Pikes Peak Community College, Colorado Springs, CO; May 1997

Connie Dean, a therapeutic treatment parent at the Institute for Attachment and Child Development, talks about when she was as a foster parent for the department of human services.